- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04228861
Investigation of Oral Microflora of Infants
Investigation of Colonization of Streptococcus Mutans, Lactobacillus Spp. and Candida Spp. in Oral Microflora in Infancy and Transmission From the Parent to the Infant
Study Overview
Status
Conditions
Detailed Description
Study sample size and design: When α = 0.05, 1-β (power) = 0.80 were taken to determine the sample volume, it was calculated that at least 46 babies should be sampled for 6 months to have an average amount of S. mutans change of 1.87 units. Considering the losses that may occur during the follow-up, the study was started by taking samples from 60 systemically healthy newborns.
The study commenced with 60 newborns and was completed with 47 infants due to losses during the follow-up. Oral swab samples were taken from 47 healthy infants within the first 24 hours after birth, at 1 month old and during the first tooth eruption. Saliva samples were taken from the mothers of all the infants and from the fathers of 20 of the infants in the last meeting.
Last interview with the parents, their oral examinations were performed, and their findings were processed as decayed (D), filled (F) and missing (M) teeth in accordance with the World Health Organization criteria, with the DMF (decayed, missing and filled) index being calculated. Furthermore, saliva samples were taken from the parents at the last interview. A questionnaire form including the sex of the infant, type of delivery, birth weight, and nutritional habits of the infant during the follow-up was filled in by gaining information from the parents on the first day and during the follow-ups.
Swab samples taken from infants with sterile swabs were transferred to the laboratory by placing sterile saline solution into dispensed 2 ml screw cap tubes. Sterile urine collection containers of 50 ml were used to collect saliva samples from the parents.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Malatya, Turkey, 44280
- Inonu University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- none of the infants or their families had systemic disease
Exclusion Criteria:
- the infants or their families have systemic disease
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acquisition of the oral streptococcus mutans in infants
Time Frame: first 24 hours after birth
|
Counts of oral streptococcus mutans
|
first 24 hours after birth
|
Acquisition of the oral streptococcus mutans in infants
Time Frame: at 1 month old
|
Counts of oral streptococcus mutans
|
at 1 month old
|
Acquisition of the oral streptococcus mutans in infants
Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
|
Counts of oral streptococcus mutans
|
4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: first 24 hours after birth
|
Counts of oral Lactobacillus and candida spp
|
first 24 hours after birth
|
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: at 1 month old
|
Counts of oral Lactobacillus and candida spp
|
at 1 month old
|
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
|
Counts of oral Lactobacillus and candida spp
|
4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: gülsüm duruk, Inonu University
- Principal Investigator: zehra b erel, Inonu University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 963
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Streptococcus Mutans
-
Cairo UniversityUnknown
-
Cairo UniversityCompletedHigh Caries Risk Patients | Streptococcus MutansEgypt
-
Didem Sakaryali UyarCompletedProbiotics | Tooth Decay | Streptococcus MutansTurkey
-
King Abdulaziz UniversityCompletedDental Caries and Streptococcus Mutans CountSaudi Arabia
-
Jordan University of Science and TechnologyCompletedOral Health | Mutans StreptococciJordan
-
University of OxfordWellcome TrustCompletedStreptococcus Agalactiae (Streptococcus Group B)Kenya
-
University of WashingtonCompleted
-
Nantes University HospitalDirection Générale de l'Offre de SoinsCompletedStreptococcus AgalactiaeFrance
-
Biosearch S.A.Federico García García, PhDUnknownStreptococcus AgalactiaeSpain
-
William Beaumont HospitalsTerminatedGroup B StreptococcusUnited States